Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C R Lummis

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biochemical Society Transactions|May 26, 2004
The transmembrane domain of the 5-HT3 receptor: its role in selectivity and gatingS C R Lummis
Biophysical Journal|April 23, 2010
Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptorM Lochner, S C R Lummis
Pesticide Biochemistry and Physiology|April 17, 2022
Characterisation of thymol effects on RDL receptors from the bee parasite Varroa destructorK L Price, S C R Lummis
British Journal of Pharmacology|March 16, 2013
Discriminating between 5-HT₃A and 5-HT₃AB receptorsA J Thompson, S C R Lummis
Current Pharmaceutical Design|November 1, 2006
5-HT3 receptorsA J Thompson, S C R Lummis
British Journal of Pharmacology|March 4, 2008
Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptorsA J Thompson, S C R Lummis
British Journal of Pharmacology|July 5, 2013
A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptorsA J Thompson, S C R Lummis
British Journal of Pharmacology|May 16, 2007
The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptorsA J Thompson, M Lochner, S C R Lummis
Biophysical Journal|October 22, 2008
Loop B is a major structural component of the 5-HT3 receptorA J Thompson, M Lochner, S C R Lummis
Molecular Pharmacology|April 21, 2011
Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptorA J Thompson, R K Duke, S C R Lummis
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biochemical Society Transactions|May 26, 2004
The transmembrane domain of the 5-HT3 receptor: its role in selectivity and gatingS C R Lummis
Biophysical Journal|April 23, 2010
Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptorM Lochner, S C R Lummis
Pesticide Biochemistry and Physiology|April 17, 2022
Characterisation of thymol effects on RDL receptors from the bee parasite Varroa destructorK L Price, S C R Lummis
British Journal of Pharmacology|March 16, 2013
Discriminating between 5-HT₃A and 5-HT₃AB receptorsA J Thompson, S C R Lummis
Current Pharmaceutical Design|November 1, 2006
5-HT3 receptorsA J Thompson, S C R Lummis
British Journal of Pharmacology|March 4, 2008
Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptorsA J Thompson, S C R Lummis
British Journal of Pharmacology|July 5, 2013
A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptorsA J Thompson, S C R Lummis
British Journal of Pharmacology|May 16, 2007
The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptorsA J Thompson, M Lochner, S C R Lummis
Biophysical Journal|October 22, 2008
Loop B is a major structural component of the 5-HT3 receptorA J Thompson, M Lochner, S C R Lummis
Molecular Pharmacology|April 21, 2011
Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptorA J Thompson, R K Duke, S C R Lummis
Pageof 2